# Wegovy, Ozempic and Rybelsus are sold directly by Novo.

*biotech · news · 2026-05-08 · The Financial Express*

## Key points

- Novo reduced Ozempic's starting dose price by 36% and Wegovy's by 48% after generics launched.
- The GLP-1 market in India tripled to Rs 1,736 crore due to generic semaglutide launches.
- Torrent Pharma now controls 38% of India's generic semaglutide market and offers the only oral generics.
- Sales of generic semaglutide jumped 238% in April compared to March, impacting tirzepatide sales.
- Innovator brands have retained strong market positions despite significant growth in generics.

**Companies:** Novo, Torrent Pharma, Zydus, Lupin
**Countries:** India

[Read the full story on The Financial Express](https://www.financialexpress.com/business/healthcare/sales-of-weight-loss-drug-wegovy-soars-70-after-steep-price-cuts-in-april/4235786/)

---

Canonical: https://newsio.io/n/eae1ff29-2ce3-45af-ba96-cead585dbbfe/wegovy-ozempic-and-rybelsus-are-sold-directly-by-novo-torrent-is-the-only-drugma
Summarized by Newsio from The Financial Express. https://newsio.io/how-it-works